Visalytics
Visalytics
approved EB-2 (NIW)

Associate Director

Translational Pathology · Turkey · 2023-10-02

Processing Time
6 days
Decision Date
2023-10-02
Location
Georgia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in translational pathology, specifically examining biobank data to investigate underlying cancer mechanisms. Her work focuses on identifying novel biomarkers to improve diagnostics, treatments, and patient outcomes for various forms of cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the global cancer burden, which is a leading cause of death, and aligns with U.S. interests in critical biotechnologies.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her M.D., extensive citation record, and history of funding from prestigious institutions like the American Cancer Society.

3 Waiver Benefit Met

On balance, it is beneficial to the U.S. to waive the labor certification because her findings are crucial for therapeutic innovation and maintaining technological leadership.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.D. degree, 8 peer-reviewed journal publications, and a significant record of 564 citations. Additional evidence included 3 peer-review assignments for reputable publications and substantial research funding from major organizations like the National Cancer Institute and the Department of Defense.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment
Reference Letters Dependent

Similar Cases

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Postdoctoral Researcher

Research and Development · India

WeGreened EB-2 (NIW) approved
New Jersey 173 days 2022-04-11
The petitioner proposes to systematically characterize genes and pathways involved in cancer development and progression using laboratory-based and animal models to study biological and clinical phenotypes. This work aims to identify novel molecular targets for cancer diagnosis, prognosis, and treatment modalities, specifically focusing on advanced breast cancer.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Turkey

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-10-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 6 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Turkey All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist